Affordable Health Insurance logo Everything You Need to Know About Affordable Health Insurance and More

  The Health & Healthcare Blog  

Sunday, June 18, 2017

Scientists Discover Drug Used to Treat Diabetes is Effective on Parkinson's

A drug called MSDC-0160 has been used for years to treat Type 2 diabetes. Scientists have now discovered that the drug is effective in slowing down the progression of Parkinson's disease. It may be a breakthrough for over 10 million people worldwide who are living with the disease.

Slows progression of Parkinson's

Parkinson's is a disease that affects the central nervous system. It is a progressive disease that slowly break's down a person's ability to move, speak and write. There is no cure for Parkinson's disease, but some drugs have been able to help alleviate some of the symptoms. However, these drugs have had undesirable side affects. Until now, no drug has been able to slow down the progression of Parkinson's.

Ready for clinical trials

MSDC-0160 was developed by Michigan-based company, Metabolic Solutions Development Company (MSDC), in Kalamazoo, Michigan. In 2012 the company began to look at finding other diseases that may be helped by existing drugs. MSDC-0160 was found effective in preserving critical brain function and in reducing inflammation and nerve cell death. After four years of work, the drug is now being prepared for clinical trials on humans with Parkinson's.

According to The Parkinson's Disease Foundation, 60,000 Americans are diagnosed with Parkinson's every year. If the clinical trials are successful, the drug may be just the breakthrough scientists have been looking for with Parkinson's. In addition, MSDC-0160 is being researched for potential use in other diseases, including Lewy body dementia and Alzheimer's.

DISCLAIMER: The content or opinions expressed on this web site are not to be interpreted as medical advice. Please consult with your doctor or medical practictioner before utilizing any suggestions on this web site.